The compound CeRhSb, crystallizing in the orthorhombic CeCu2-type structure, has been synthesized. Its unit-cell volume is anomalous in relation to that of isostructural RRhSb (R =rare earth) compounds.Its magnetic susceptibility is weakly temperature dependent and exhibits a
We have developed a simple precipitation route to synthesize magnetite (Fe 3 O 4 ) nanoparticles with controlled size without any requirement of calcination step at high temperatures. The study of these nano-particles indicates an enhancement in saturation magnetization with reduction in size down to ~10 nm beyond which the magnetization reduces. The latter is attributed to surface effects becoming predominant as surface to core volume ratio increases. From the view -point of applications, 10 nm size of magnetite particles seems to be the optimum.
The perovskite La1/3Sr2/3FeO3−δ
was investigated by neutron diffraction, magnetic and Mössbauer
spectroscopy measurements. La1/3Sr2/3FeO3−δ undergoes magnetic
ordering at T = 190–200
K accompanied by charge disproportionation. Magnetic peaks due to charge ordering are
observed below 200 K. The charge ordering is gradually developed below 200 K along
with a charge disproportionation, 2Fe4+ ⇒ Fe3+ + Fe5+.
La1/3Sr2/3FeO3−δ
shows an antiferromagnetic structure at low temperature.
Magnetic moments of about 3 and 1.3 μB
were obtained from the neutron diffraction data refinement for Fe3+ and
Fe5+
at 15 K, respectively, which suggest that both Fe ions are in a low spin state. These
values are significantly lower than those reported by Battle et al for La1/3Sr2/3FeO2.98.
Mössbauer spectra indicate that full charge ordering might be reached below 20 K with no Fe4+.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.